BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 37127652)

  • 21. Disruption of rack1 suppresses SHH-type medulloblastoma formation in mice.
    Liu F; Shao J; Yang H; Yang G; Zhu Q; Wu Y; Zhu L; Wu H
    CNS Neurosci Ther; 2021 Dec; 27(12):1518-1530. PubMed ID: 34480519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipidome signatures of metastasis in a transgenic mouse model of sonic hedgehog medulloblastoma.
    Huang D; Liu J; Eldridge RC; Gaul DA; Paine MRL; Uppal K; MacDonald TJ; Fernández FM
    Anal Bioanal Chem; 2020 Oct; 412(25):7017-7027. PubMed ID: 32794007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma.
    Genovesi LA; Millar A; Tolson E; Singleton M; Hassall E; Kojic M; Brighi C; Girard E; Andradas C; Kuchibhotla M; Bhuva DD; Endersby R; Gottardo NG; Bernard A; Adolphe C; Olson JM; Taylor MD; Davis MJ; Wainwright BJ
    Genome Med; 2021 Jun; 13(1):103. PubMed ID: 34154646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low Expression of the
    de Araújo MA; Malafaia O; Ribas Filho JM; Fratini L; Roesler R; Isolan GR
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BarTeL, a Genetically Versatile, Bioluminescent and Granule Neuron Precursor-Targeted Mouse Model for Medulloblastoma.
    Shackleford GM; Shi XH; Swanson KS; Mahdi MY; Gonzalez-Gomez I; Asgharzadeh S; D'Apuzzo M; Erdreich-Epstein A; Moats RA
    PLoS One; 2016; 11(6):e0156907. PubMed ID: 27310018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I and phase II sonidegib and vismodegib clinical trials for the treatment of paediatric and adult MB patients: a systemic review and meta-analysis.
    Li Y; Song Q; Day BW
    Acta Neuropathol Commun; 2019 Jul; 7(1):123. PubMed ID: 31362788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustained hedgehog signaling in medulloblastoma tumoroids is attributed to stromal astrocytes and astrocyte-derived extracellular matrix.
    Cheng Y; Franco-Barraza J; Wang Y; Zheng C; Zhang L; Qu Y; Long Y; Cukierman E; Yang ZJ
    Lab Invest; 2020 Sep; 100(9):1208-1222. PubMed ID: 32457352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serpine2/PN-1 Is Required for Proliferative Expansion of Pre-Neoplastic Lesions and Malignant Progression to Medulloblastoma.
    Vaillant C; Valdivieso P; Nuciforo S; Kool M; Schwarzentruber-Schauerte A; Méreau H; Cabuy E; Lobrinus JA; Pfister S; Zuniga A; Frank S; Zeller R
    PLoS One; 2015; 10(4):e0124870. PubMed ID: 25901736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocyte growth factor and sonic Hedgehog expression in cerebellar neural progenitor cells costimulate medulloblastoma initiation and growth.
    Binning MJ; Niazi T; Pedone CA; Lal B; Eberhart CG; Kim KJ; Laterra J; Fults DW
    Cancer Res; 2008 Oct; 68(19):7838-45. PubMed ID: 18829539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paired box gene 8 (PAX8) expression is associated with sonic hedgehog (SHH)/wingless int (WNT) subtypes, desmoplastic histology and patient survival in human medulloblastomas.
    Harter PN; Baumgarten P; Zinke J; Schilling K; Baader S; Hartmetz AK; Schittenhelm J; Beschorner R; Liebner S; Schulte D; Plate KH; Gutwein P; Korshunov A; Pfister SM; Jones DT; Doberstein K; Mittelbronn M
    Neuropathol Appl Neurobiol; 2015 Feb; 41(2):165-79. PubMed ID: 25287489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of WNT signaling attenuates self-renewal of SHH-subgroup medulloblastoma.
    Rodriguez-Blanco J; Pednekar L; Penas C; Li B; Martin V; Long J; Lee E; Weiss WA; Rodriguez C; Mehrdad N; Nguyen DM; Ayad NG; Rai P; Capobianco AJ; Robbins DJ
    Oncogene; 2017 Nov; 36(45):6306-6314. PubMed ID: 28714964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SOX9 Defines Distinct Populations of Cells in SHH Medulloblastoma but Is Not Required for Math1-Driven Tumor Formation.
    Adolphe C; Millar A; Kojic M; Barkauskas DS; Sundström A; Swartling FJ; Hediyeh-Zadeh S; Tan CW; Davis MJ; Genovesi LA; Wainwright BJ
    Mol Cancer Res; 2021 Nov; 19(11):1831-1839. PubMed ID: 34330843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sox2 requirement in sonic hedgehog-associated medulloblastoma.
    Ahlfeld J; Favaro R; Pagella P; Kretzschmar HA; Nicolis S; Schüller U
    Cancer Res; 2013 Jun; 73(12):3796-807. PubMed ID: 23596255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. O-GlcNAcylation promotes cerebellum development and medulloblastoma oncogenesis via SHH signaling.
    Chen L; Li Y; Song Z; Xue S; Liu F; Chang X; Wu Y; Duan X; Wu H
    Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2202821119. PubMed ID: 35969743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pik3ca mutations significantly enhance the growth of SHH medulloblastoma and lead to metastatic tumour growth in a novel mouse model.
    Niesen J; Ohli J; Sedlacik J; Dührsen L; Hellwig M; Spohn M; Holsten T; Schüller U
    Cancer Lett; 2020 May; 477():10-18. PubMed ID: 32112900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Foretinib is effective therapy for metastatic sonic hedgehog medulloblastoma.
    Faria CC; Golbourn BJ; Dubuc AM; Remke M; Diaz RJ; Agnihotri S; Luck A; Sabha N; Olsen S; Wu X; Garzia L; Ramaswamy V; Mack SC; Wang X; Leadley M; Reynaud D; Ermini L; Post M; Northcott PA; Pfister SM; Croul SE; Kool M; Korshunov A; Smith CA; Taylor MD; Rutka JT
    Cancer Res; 2015 Jan; 75(1):134-46. PubMed ID: 25391241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma.
    Brun SN; Markant SL; Esparza LA; Garcia G; Terry D; Huang JM; Pavlyukov MS; Li XN; Grant GA; Crawford JR; Levy ML; Conway EM; Smith LH; Nakano I; Berezov A; Greene MI; Wang Q; Wechsler-Reya RJ
    Oncogene; 2015 Jul; 34(29):3770-9. PubMed ID: 25241898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GSK-3 modulates SHH-driven proliferation in postnatal cerebellar neurogenesis and medulloblastoma.
    Ocasio JK; Bates RDP; Rapp CD; Gershon TR
    Development; 2019 Oct; 146(20):. PubMed ID: 31540917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Developmental basis of SHH medulloblastoma heterogeneity.
    Gold MP; Ong W; Masteller AM; Ghasemi DR; Galindo JA; Park NR; Huynh NC; Donde A; Pister V; Saurez RA; Vladoiu MC; Hwang GH; Eisemann T; Donovan LK; Walker AD; Benetatos J; Dufour C; Garzia L; Segal RA; Wechsler-Reya RJ; Mesirov JP; Korshunov A; Pajtler KW; Pomeroy SL; Ayrault O; Davidson SM; Cotter JA; Taylor MD; Fraenkel E
    Nat Commun; 2024 Jan; 15(1):270. PubMed ID: 38191555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HDL nanoparticles targeting sonic hedgehog subtype medulloblastoma.
    Bell JB; Rink JS; Eckerdt F; Clymer J; Goldman S; Thaxton CS; Platanias LC
    Sci Rep; 2018 Jan; 8(1):1211. PubMed ID: 29352211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.